PURLS / PEER REVIEWED

Tamsulosin for Patients With Ureteral Stones?

Author and Disclosure Information

 

References

CAVEATS

What about proximal or XL stones?

Only distal stones were included in seven of the eight trials in this analysis. Thus, this meta-analysis was unable to determine the effect on more proximal stones. Also, it’s unclear if the drug provides any benefit with stones > 10 mm in size.

CHALLENGES TO IMPLEMENTATION

None worth mentioning

We see no challenges to implementation of this recommendation.

ACKNOWLEDGEMENT

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

Copyright © 2018. The Family Physicians Inquiries Network. All rights reserved.

Reprinted with permission from the Family Physicians Inquiries Network and The Journal of Family Practice (2018; 67[1]:37-38).

Pages

Recommended Reading

When to Discontinue RAAS Therapy in CKD Patients
Clinician Reviews
Bariatric Surgery for CKD
Clinician Reviews
How Low Should You Go? Optimizing BP in CKD
Clinician Reviews
HTN in CKD: How Should I Be Treating It?
Clinician Reviews
Do PPIs Pose a Danger to Kidneys?
Clinician Reviews
How to Interpret Positive Troponin Tests in CKD
Clinician Reviews
Acute Management of Severe Asymptomatic Hypertension
Clinician Reviews
The National Kidney Foundation Names Clinician Reviews® Recipient of the 2018 Nostradamus Award
Clinician Reviews
For Patients With CKD, Don’t Wait—Vaccinate!
Clinician Reviews
Dental Health: What It Means in Kidney Disease
Clinician Reviews